Searchable abstracts of presentations at key conferences in endocrinology

ea0023oc5.6 | Oral Communications 5 | BSPED2009

Ongoing benefit of CSII in the improvement of HbAlc and BMI in a cohort of children with type I diabetes

Onwuneme Chike , Devenney Dympna , Corcoran Fiona , McDonnell Ciara , Murphy Nuala

Introduction: Tight metabolic control reduces the risk of microvascular complications in individuals with type 1 diabetes (T1DM). Multiple studies have shown improvements in quality of life (QOL) in children following the introduction of continuous subcutaneous insulin infusion (CSII) but metabolic outcomes have been more variable. This audit looked at metabolic parameters at long-term follow up in children and adolescents using CSII over 3 years.Methods...

ea0027p44 | (1) | BSPED2011

The use of continuous s.c. insulin infusion therapy to optimize glycaemic control in children with type 1 diabetes mellitus

Carroll Aoife , Devenney Dympna , Corcoran Fiona , Shaughnessy Norma , Hayden Yvonne , Murphy Nuala

Aim: To investigate the glycaemic control of patients with T1DM before and after the introduction of CSII therapy.Methods: All patients with T1DM receiving CSII therapy for more than 6 months attending the Children’s University Hospital from 2005–2011 were included. Glycosylated haemoglobin (HbA1c) was recorded 12 and 6 months prior to starting therapy, at the time of CSII initiation and annually thereafter. Adverse events and BMI were also rec...

ea0090oc10.2 | Oral Communications 10: Diabetes, Obesity, Metabolism and Nutrition 2 | ECE2023

Characterization of the insulinotropic and glucose lowering actions of hybridized amphibian host defence peptide, tigerinin-1R

Abiodun Falobi Ayodele , Edeani Joy Nneka , Ofosu Wendy Amy , Smyth Lesley , Corcoran Olivia , Dunmore Simon , Ojo Opeolu

Aim: Our previous studies indicated the potential antidiabetic actions of the amphibian host-defence peptide, tigerinin-1. Tigerinin-1R was conjugated with gastric inhibitory polypeptide (GIP) as part of strategies for further development of its therapeutic effects. This study characterises the insulin-releasing and cytotoxic properties of the resulting hybrid peptide.Method: Pure G-TGN was commercially synthesized G-TGN. Insulin releasing effects were a...

ea0068p13 | Abstracts | UKINETS2019

Timing of peptide receptor radiotargeted therapy in relation to cardiac valve surgery for carcinoid heart disease in patients with neuroendocrine metastases and cardiac syndrome: a single centre study from a centre of excellence

Davis LM , Nicou N , Martin W , Corcoran B , Mulholland N , Srirajaskanthan R , Ramage J , Wendler O , Vivian G

Introduction: Perioperative mortality of patients who undergo heart valve surgery for carcinoid heart valve disease (CHVD) has been observed to be high (5–10%). We investigated whether peptide receptor radiotherapy (PRRT) with Lutetium-177 Dotatate can be used safely in patients with neuroendocrine neoplasms (NEN) and CHVD and if there is an associated survival advantage by reducing overall exposure of the valves to high doses of vasoactive peptides.<p class="abstext"...

ea0086p194 | Endocrine Cancer and Late Effects | SFEBES2022

The incidence and clinical significance of metabolically active brown adipose tissue in patients with pheochromocytomas and paragangliomas: A retrospective cohort study, systematic review and meta-analysis

Onyema Michael , Ostarijas Eduard , Minhas Raisa , Roy Aparajita , Kearney Jessica , Omran Asma , Zair Zoulikha , Reynolds Saira , Mulholland Nicola , Corcoran Benjamin , Halim Mohammad , Aylwin Simon , Dimitriadis Georgios K

There is limited research into the impact of active brown adipose tissue (aBAT) in patients with phaeochromocytomas and paragangliomas (PPGLs). A small body of evidence has shown that patients with PPGL patients can exhibit a high prevalence for aBAT recognized as ranging between 8 - 28% without specific correlation to germline mutations. Furthermore, it has been suggested that aBAT may be linked to increased mortality. Systematic searches of the Medical Literature Analysis an...

ea0034p213 | Obesity, diabetes, metabolism and cardiovascular | SFEBES2014

Renal function variation after bariatric surgery: which measurement do we rely on?

Bakhshi Saloni , Barrett Abigail , Nayak Ananth , Varughese George , Cheruvu Chandra , Varadhan Lakshminarayanan

Introduction: Interpretation of renal function in patients with obesity and post-bariatric surgery is a clinical challenge. EGFR could be falsely low and weight loss does not reflect muscle mass. The aim of our study was to compare the fluctuations in renal function assessment in patients undergoing bariatric surgery.Methods: 200 patients who underwent bypass surgery or sleeve gastrectomy were analysed. Six different renal function parameters were analys...